Needle exchange programs, more commonly called syringe services programs (SSPs), are community-based public health programs that provide sterile syringes and safe disposal of used ones to people who inject drugs. Their core purpose is reducing the spread of infectious diseases like HIV and hepatitis C, but most programs today offer far more than just clean needles. They function as a front door to healthcare for people who often have no other point of contact with the medical system.
Services Beyond Clean Needles
The name “needle exchange” undersells what these programs actually do. According to the CDC and HIV.gov, a typical syringe services program offers a bundle of services that includes:
- Sterile syringes and injection supplies, plus safe disposal of used equipment
- Testing and vaccination for HIV, hepatitis B, and hepatitis C
- Linkage to treatment for both infectious diseases and substance use disorders
- Naloxone distribution, providing the overdose-reversal medication to participants and their social networks
- Wound and abscess care for injection-related skin infections
- Education on safer injection practices and overdose prevention
- Referrals to mental health services, social services, and other medical care
For many participants, an SSP visit is the only time they interact with someone trained in healthcare. That makes these programs a critical bridge. A person who walks in for clean syringes might leave with a hepatitis C test result, a naloxone kit, or a referral to a treatment program they didn’t know existed.
How They Prevent Disease
When people share or reuse syringes, small amounts of blood left inside the needle can transmit bloodborne infections. HIV and hepatitis C are the two biggest risks. Hepatitis C is especially efficient at spreading this way because the virus can survive in a used syringe for weeks.
By providing a reliable supply of sterile equipment, SSPs break that chain of transmission. The logic is straightforward: if every injection uses a fresh needle, there’s no contaminated blood to pass from one person to the next. Decades of research have established that these programs reduce HIV transmission among people who inject drugs. They also expand testing and vaccination, catching infections that would otherwise go undiagnosed and untreated for years.
Overdose Reversal: A Growing Role
As the overdose crisis has intensified, syringe services programs have become one of the largest distributors of naloxone in the country. Naloxone is a medication that can reverse an opioid overdose within minutes, and SSPs put it directly into the hands of the people most likely to witness one.
The scale of this work is significant. In North Carolina alone, SSPs distributed over 109,000 naloxone kits in the 2022-2023 reporting year. Those kits led to at least 16,712 reported overdose reversals, a number that rose more than 10% from the prior year. Even that figure is likely an undercount, since many reversals go unreported. Multiply that kind of impact across programs in dozens of states, and SSPs are quietly preventing thousands of deaths each year.
One-for-One vs. Needs-Based Models
Not all programs operate the same way. The two main distribution models differ in a way that matters for both participants and public safety.
In a one-for-one model, a participant can only receive as many clean syringes as they bring in used ones. This sounds intuitive, but it creates real problems. People have to collect and carry used needles until their next visit, which increases the risk of accidental needlestick injuries. It also means a person found carrying used syringes could face arrest for drug paraphernalia possession, depending on local laws.
In a needs-based model, participants receive however many syringes they need to inject safely until their next visit, regardless of how many they return. Both the CDC and the Substance Abuse and Mental Health Services Administration support the needs-based approach as the more effective model. Research consistently shows it leads to better outcomes: fewer shared needles, fewer publicly discarded syringes, and more consistent program engagement. Despite this, some states still mandate one-for-one exchange by law.
The Gateway to Treatment
One of the most persistent concerns about SSPs is that providing clean supplies might enable or prolong drug use. The evidence points in the opposite direction. Because these programs build trust with a population that often avoids traditional healthcare settings, they become a natural pathway into substance use treatment. People who use SSPs are more likely to enter treatment than people who inject drugs but don’t use these services.
This makes sense when you consider the relationship. Many people who inject drugs have had negative experiences with the healthcare system, whether through stigma, lack of insurance, or past trauma. SSPs meet people where they are, without requiring sobriety as a condition of care. Over time, that consistent, nonjudgmental contact creates openings for conversations about treatment readiness. Staff can make warm referrals, helping participants navigate intake processes and connecting them to programs that have availability.
How Programs Are Funded and Regulated
The legal landscape for syringe services programs varies dramatically by state. Some states have explicit laws authorizing SSPs, while others restrict or prohibit them. Local regulations, zoning rules, and paraphernalia laws all shape whether and how a program can operate in a given community.
At the federal level, funding for SSPs has been subject to shifting restrictions over the years. Federal dollars have been permitted to support certain SSP operations, including staffing, testing, and naloxone distribution. However, restrictions have historically prohibited the use of federal funds to purchase the syringes themselves. This means many programs rely on a patchwork of state grants, private donations, and foundation funding to cover the cost of their most basic supply.
Organizations like NASTAD (the National Alliance of State and Territorial AIDS Directors) channel federal funding to help SSPs hire and retain staff, expand viral hepatitis testing and vaccination, and build out referral networks. But funding remains inconsistent, and many programs operate on thin budgets with limited staff, particularly in rural areas where the need for services has grown sharply alongside rising rates of injection drug use.
What a Visit Looks Like
Walking into a syringe services program is low-barrier by design. Most don’t require identification, insurance, or proof of residency. A first visit typically involves a brief intake conversation, not an interrogation, but enough to understand what supplies and services someone needs. Participants receive sterile syringes, alcohol swabs, tourniquets, cookers, and sharps containers for safe disposal.
Many programs also offer rapid testing for HIV and hepatitis C on-site, with results available in minutes. If a test comes back positive, staff can connect the person to treatment that same day in some cases. Vaccination for hepatitis A and B is commonly available as well. For people dealing with abscesses or skin infections from injecting, some programs provide basic wound care or referrals to clinics that will.
The atmosphere tends to be informal and intentionally non-clinical. Many SSP staff members have lived experience with substance use themselves, which helps build the kind of trust that keeps people coming back. That return engagement is the whole point: every repeat visit is another chance to offer testing, treatment referrals, naloxone, and support.